nejm semaglutide ckd and Cardiovascular Outcomes in Patients with Type 2 Diabetes Presented at the 61st ERA

Dual-agonista aktywuje dwa receptory inkretynowe o odrbnych rolach metabolicznych

Heres what the research shows it can do: Stimulate new blood vessel growth to injured areas (angiogenesis) Accelerate healing in tendons, ligaments, and connective tissue Reduce inflammation without suppressing immune function Protect nerve cells and support nerve regeneration Promote cartilage repair and joint tissue recovery The anti-inflammatory effect without immune suppression is particularly notable

One theory is that it helps reduce levels of pro-inflammatory proteins in the body that are associated with heart disease, according to a study published in 2019 (5)

Overall, Med+ members reached a 21% average weight loss at 12 months and maintained a 20.5% average weight loss at 24 months